In this Viewpoint, Michael Farkouh and colleagues question the evidence that C-reactive protein (CRP) is an independent predictor of future cardiovascular events. They suggest that failure to adjust for all components of the metabolic syndrome (MetS) in previous studies has bought into question the value of CRP over established traditional risk factors. The authors postulate that CRP is only a marker of the MetS and has limited incremental value in cardiovascular risk stratification.
- Michael E Farkouh
- Sameer Bansilal
- Verghese Mathew
